CERRONE GABRIELE M 4

What Happened
Gabriele M. Cerrone, reported as a 10% owner of Tiziana Life Sciences Ltd (TLSA), acquired 15,000 shares on June 12, 2026 via an award/grant (transaction code A) at $1.11 per share, a total value of approximately $16,650. This filing reports an acquisition (addition to holdings) rather than a sale.

Key Details

• Transaction date: June 12, 2026 — 15,000 shares at $1.11 each (total ≈ $16,650)
• Form 4 filed: June 17, 2026 (5 days after the transaction) — appears to be one business day late under the standard two-business-day Form 4 filing rule
• Insider role: 10% owner (significant shareholder), not necessarily an executive/director trade
• Shares owned after the transaction: not specified in the information provided
• Transaction code A indicates an award/grant or other acquisition (not an open-market purchase); no footnotes or 10b5-1, tax‑withholding, or cashless‑exercise indications provided

Context
An "A" code award typically reflects a grant or other company-provided issuance rather than a market purchase; such acquisitions increase insider holdings but do not by themselves indicate management intent to buy or sell. For retail investors, purchases/awards can be more informative than sales, but remember this filing alone doesn't reveal the reason for the grant (compensation, conversion, settlement, etc.).